MIAMI, May 6, 2009 (GLOBE NEWSWIRE) -- Noven Pharmaceuticals, Inc. (Nasdaq:NOVN) today announced that Peter Brandt, Noven's President & Chief Executive Officer, is scheduled to present an update on Noven's business and prospects at the Deutsche Bank 34th Annual Health Care Conference in Boston on Monday, May 18th at 8:40 a.m. ET. The presentation will be webcast live at www.noven.com, and a rebroadcast will be available thereafter for at least two weeks at the same site.
About Noven
Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. Noven's business and operations are focused in three principal areas -- transdermal drug delivery, the Novogyne Pharmaceuticals joint venture, and Noven Therapeutics, Noven's specialty pharmaceutical marketing and sales unit. Noven is committed to developing and offering products and technologies that meaningfully benefit patients, its customers and its industry partners. For more information, visit www.noven.com.
The Noven Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5938